Literature DB >> 1587986

Pessaries in the geriatric patient.

M P Zeitlin1, T B Lebherz.   

Abstract

Pessaries have been used for centuries in the management of uterine prolapse. Although surgical repair has been popularized by surgeons and gynecologists for younger women with pelvic relaxation, pessaries remain a useful palliative strategy for patients who refuse surgery or represent higher operative risks. Despite the fact that pessaries are commonly used today, there is scant geriatric literature to describe their use among elderly patients. This article will review the indications and management of pessaries among elderly women with the goal of preventing complications and promoting investigation for their clinical application.

Entities:  

Mesh:

Year:  1992        PMID: 1587986     DOI: 10.1111/j.1532-5415.1992.tb02118.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  5 in total

Review 1.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

2.  The history and evolution of pessaries for pelvic organ prolapse.

Authors:  Sheetle M Shah; Abdul H Sultan; Ranee Thakar
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-14

3.  Pessary use in advanced pelvic organ prolapse.

Authors:  Kenneth Powers; George Lazarou; Andrea Wang; Julie LaCombe; Giti Bensinger; Wilma M Greston; Magdy S Mikhail
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-05-10

4.  Survey of the characteristics and satisfaction degree of the patients using a pessary.

Authors:  Sang Wook Bai; Bo Sung Yoon; Ja Young Kwon; Jong Seung Shin; Sei Kwang Kim; Ki Hyun Park
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-12-01

5.  An erosive pessary.

Authors:  Osei K Kankam; Richard Geraghty
Journal:  J R Soc Med       Date:  2002-10       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.